Cargando…

Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164

Detalles Bibliográficos
Autores principales: Joseph, Boney, Nunez, Nicolas A., Kung, Simon, Vande Voort, Jennifer L., Pazdernik, Vanessa K., Schak, Kathryn M., Boehm, Stacey M., Carpenter, Brooke, Johnson, Emily K., Malyshev, Grigoriy, Smits, Nathan, Adewunmi, Daniel O., Brown, Sarah K., Singh, Balwinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674743/
https://www.ncbi.nlm.nih.gov/pubmed/38004498
http://dx.doi.org/10.3390/ph16111571
_version_ 1785140900091920384
author Joseph, Boney
Nunez, Nicolas A.
Kung, Simon
Vande Voort, Jennifer L.
Pazdernik, Vanessa K.
Schak, Kathryn M.
Boehm, Stacey M.
Carpenter, Brooke
Johnson, Emily K.
Malyshev, Grigoriy
Smits, Nathan
Adewunmi, Daniel O.
Brown, Sarah K.
Singh, Balwinder
author_facet Joseph, Boney
Nunez, Nicolas A.
Kung, Simon
Vande Voort, Jennifer L.
Pazdernik, Vanessa K.
Schak, Kathryn M.
Boehm, Stacey M.
Carpenter, Brooke
Johnson, Emily K.
Malyshev, Grigoriy
Smits, Nathan
Adewunmi, Daniel O.
Brown, Sarah K.
Singh, Balwinder
author_sort Joseph, Boney
collection PubMed
description
format Online
Article
Text
id pubmed-10674743
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106747432023-11-07 Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164 Joseph, Boney Nunez, Nicolas A. Kung, Simon Vande Voort, Jennifer L. Pazdernik, Vanessa K. Schak, Kathryn M. Boehm, Stacey M. Carpenter, Brooke Johnson, Emily K. Malyshev, Grigoriy Smits, Nathan Adewunmi, Daniel O. Brown, Sarah K. Singh, Balwinder Pharmaceuticals (Basel) Correction MDPI 2023-11-07 /pmc/articles/PMC10674743/ /pubmed/38004498 http://dx.doi.org/10.3390/ph16111571 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Joseph, Boney
Nunez, Nicolas A.
Kung, Simon
Vande Voort, Jennifer L.
Pazdernik, Vanessa K.
Schak, Kathryn M.
Boehm, Stacey M.
Carpenter, Brooke
Johnson, Emily K.
Malyshev, Grigoriy
Smits, Nathan
Adewunmi, Daniel O.
Brown, Sarah K.
Singh, Balwinder
Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164
title Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164
title_full Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164
title_fullStr Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164
title_full_unstemmed Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164
title_short Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164
title_sort correction: joseph et al. efficacy of ketamine with and without lamotrigine in treatment-resistant depression: a preliminary report. pharmaceuticals 2023, 16, 1164
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674743/
https://www.ncbi.nlm.nih.gov/pubmed/38004498
http://dx.doi.org/10.3390/ph16111571
work_keys_str_mv AT josephboney correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT nuneznicolasa correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT kungsimon correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT vandevoortjenniferl correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT pazdernikvanessak correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT schakkathrynm correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT boehmstaceym correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT carpenterbrooke correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT johnsonemilyk correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT malyshevgrigoriy correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT smitsnathan correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT adewunmidanielo correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT brownsarahk correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164
AT singhbalwinder correctionjosephetalefficacyofketaminewithandwithoutlamotrigineintreatmentresistantdepressionapreliminaryreportpharmaceuticals2023161164